AGM/EGM31 Aug 2026, 01:06 pm
Bacil Pharma Ltd Announces 39th AGM and Annual Report 2025-26
AI Summary
Bacil Pharma Ltd has submitted its Annual Report for the Financial Year 2025-26 and the Notice for its 39th Annual General Meeting (AGM). The AGM is scheduled for September 23rd, 2026, and will be conducted via Video Conference or other audio-visual means (OAVM). Key agenda items include the adoption of the audited financial statements for FY 2025-26 and the re-appointment of Ms. Chaitali Kalpataru Shah as a director retiring by rotation. The report also details changes in the Board of Directors and Key Managerial Personnel (KMP) during the fiscal year, including resignations and appointments.
Key Highlights
- Annual Report for FY 2025-26 submitted.
- 39th AGM scheduled for September 23, 2026, via VC/OAVM.
- Adoption of audited financial statements is a key agenda item.
- Director re-appointment and board changes are noted.
Price Impact
More from BACPHAR